Trials / Not Yet Recruiting
Not Yet RecruitingNCT07211932
Tofacitinib in Juvenile Idiopathic Arthritis
Efficacy of Tofacitinib in Patients With Juvenile Idiopathic Arthritis: A Study Based on Real-world Clinical Practice Data.
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 58 (estimated)
- Sponsor
- Consorci Sanitari de l'Alt Penedès i Garraf · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate, using real-world clinical practice data, the efficacy of tofacitinib in improving the clinical control of juvenile idiopathic arthritis (JIA) after 12 months of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tofacitinib | Patients received tofacitinib for the treatment of juvenile idiopathic arthritis (JIA). |
Timeline
- Start date
- 2025-12-01
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2025-10-08
- Last updated
- 2025-11-26
Locations
3 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT07211932. Inclusion in this directory is not an endorsement.